Manajemen Anestesi Gravida dengan Plasenta Akreta yang dilakukan Seksio Sesarea dengan Transarterial Ballooning
Abstract
Bleeding before (antepartum) and after (postpartum) delivery remains a major contributor to perinatal mortality and maternal morbidity worldwide. Placenta accreta is a cause of maternal morbidity and mortality, recently becoming the most common reason for emergency postpartum hysterectomy.
A 35-year-old woman weighing 55 kg, height 151 cm, G3P1101Ab000 at a gestational age of 34-36 weeks, with a history of antepartum bleeding and suspicion of placenta accreta from the ultrasound, is scheduled for pregnancy termination via cesarean section. Before the surgery, a transarterial balloon catheter is inserted, and the estimated blood loss during the operation is around 10,000 ml.
In this patient, the choice of general anesthesia is made considering the history of third-trimester bleeding, a high probability index score of 51% for accreta, and the plan for hysterectomy, leading to an anticipated prolonged operation time. Additionally, the risk of significant bleeding during the surgery prompts the selection of general anesthesia for hemodynamic management, and the placement of a catheter balloon is done to anticipate massive bleeding.
To obtain a more comprehensive comparison and understanding of estimated blood loss, a comparison with other cases involving catheter balloon procedures before or after surgery is needed.
Downloads
References
Giordano R, Cacciatore A, Cignini P, Vigna R, Romano M. Antepartum haemorrhage. J Prenat Med. 2010; 4(1): 12-6.
Landau Ruth, Ciliberto CG, and Vuilleumier. Management of obstetric hemorrhage, chapter 20. Dalam: Santos A.C, Epstein JN., Chaudhuri Kallol. Clinical Anesthesiology Guide: Obstetric Anesthesia 1st ed. Mc. Graw Hill. New York. 2015; 357.
Banayan JM, Hofer JE, and Scavone BM. Antepartum and postpartum hemorrhage. Dalam: Chestnut DH, Wong CA, Tsen LC, Ngan Kee WD, Beilin Y, Mhyre JM. Obstetric Anesthesia Principles and Practice, 6th edition, chapter 37. Philadelphia: Elsevier. 2020; 901. (et al sampai orang ke 6)
Walton Zachary, Snegovskikh Denis, and Braveman Ferne. Pregnancy-associated diseases. Stoelting’s Anesthesia and Co-Existing Disease. 7th Edition. Philadelphia: Elsevier. 2018; Chapter 31: 671–93.
Sze-yan Cheung C, Chong-pun Chan B. The sonographic appearance and obstetric management of placenta accreta. Int J Women’s Health. 2012;4: 587–94. Doi: https://doi.org/10.2147/IJWH.S28853
Wijaya DW, Uyun Y, dan Rahardjo S. Penggunaan skor indeks plasenta akreta (IPA) sebagai prediktor manajemen perioperatif seksio sesarea pasien dengan plasenta previa totalis suspek akreta. JAOI. 2020;3(2): 111-18. Doi: https://doi.org/10.47507/obstetri.v3i2.47
Landau Ruth, Ciliberto CG, and Vuilleumier. Management of obstetric hemorrhage, chapter 20. Dalam: Santos A.C, Epstein JN., Chaudhuri Kallol. Clinical Anesthesiology Guide: Obstetric Anesthesia 1st ed. Mc. Graw Hill. New York. 2015; 357.
Wright JD, Devine P, Shah M, Gaddipati S, Lewin SN, Simpson LL, et al. Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol. 2010;115(6):1187–193. Doi: https://doi.org/10.1097/AOG.0b013e3181df94fb
Ismail S. Placenta accreta: anesthetic management and resuscitation strategies. Anaesth Pain & intensive Care 2014;18(4):371–76.
Committee on Obstetric Practice. Placenta accreta. Committee opinion No.529. American college of obstetrician and Gynecologists. Obstet Gynecol 2012;120(1):207-11. Doi: https://doi.org/10.1097/AOG.0b013e318262e340.
KN Cheng K, MH Lee M. Rising incidence of morbidly adherent placenta and its association with previous caesarean section: A 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J. 2015;21(6):511–7. Doi: https://doi.org/ 10.12809/hkmj154599
Li P, Liu X, Li X, Wei X, Liao J. Clinical outcomes and anesthetic management of pregnancies with placenta previa and suspicion for placenta accreta undergoing intraoperative abdominal aortic balloon occlusion during cesarean section. BMC Anesthesiol. 2020;20(1):1–9. Doi: https://doi.org/10.1186/s12871-020-01040-8
Martin Erin dan Archer Thomas. Placenta accreta syndrome. Dalam: Silver Robert, ed. Series in Maternal-Fetal Medicine. 1st editon CRC Press, Francis. 2017; 137–148
Guasch E, Montenegro P, Ochoa C, Schiraldi R, Díez J, Gilsanza F. Anestesia general hemorragia obstétrica con transfusión en la cesárea. Experiencia durante un año en un hospital universitario. Rev Esp Anestesiol Reanim [Internet]. 2012;59(8):415–22. Tersedia dari: https://medes.com/publication/76738
Mallawaarachchi R, Pallemulla R. Perioperative anesthetic management of a pregnant mother with placenta percreta. J Obstet Anaesth Crit Care. 2018;8(2):99.
Eller A, Porter TF, Soisson P, Silver R. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–54. Doi: https://doi.org/10.1111/j.1471-0528.2008.02037.x
Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010;116(4):835–42. Doi: https://doi.org/10.1097/AOG.0b013e3181f3588d
Kato R, Terui K, Yokota K, Watanabe M, Uokawa R, Miyao H. Anesthetic management for cases of placenta accreta presented for cesarean section: a 7-year single-center experience. Masui. 2008;57(11):1421–26.
Akinlaja O. Hematological changes in pregnancy - The preparation for intrapartum blood loss. Obstet Gynecol Int J. 2016;4(3):1–4. Doi: https://doi.org/10.15406/ogij.2016.04.00109
Lilker SJ, Meyer RA, Downey KN, MacArthur AJ. Anesthetic considerations for placenta accreta. Int J Obstet Anesth [Internet]. 2011;20(4):288–92. Tersedia dari: https://pubmed.ncbi.nlm.nih.gov/21840207/
Rosen T. Placenta accreta and cesarean scar pregnancy: Overlooked costs of the rising cesarean section rate. Clin Perinatol 2008;35(3):519–29. Doi: https://doi.org/10.1016/j.clp.2008.07.003
Sawhney C, Subramanian A, Kaur M, Anjum A, Albert, Soni KD, et al. Assessment of hemostatic changes after crystalloid and colloid fluid preloading in trauma patients using standard coagulation parameters and thromboelastography. Saudi J Anaesth. 2013;7(1):48–56. Doi: https://doi.org/10.4103/1658-354X.109809
Leibner E, Andreae M, Galvagno SM, Scalea T. Damage control resuscitation. Clin Exp Emerg Med. 2020;7(1):5–13. Doi: https://doi.org/10.15441/ceem.19.089
Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248(3):447–58. Doi: https://doi.org/10.1097/SLA.0b013e318185a9ad
Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z,Ronsmans C, Allen E, Roberts I. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled. [Internet] Trials 2010;11:40. Tersedia dari: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864262/
Magon N, Babu KM, Kapur K, Chopra S, Joneja GS. Recombinant activated factor VII in post partum haemorrhage. Niger Med J. 2013;54(5):289-94. Doi: https://doi.org/10.4103/0300-1652.122328
Lewis NR, Brunker P, Lemire SJ, Kaufman Rm. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Transfusion 2009;49(4):689–95. Doi: https://doi.org/10.1111/j.1537-2995.2008.02029.x
Mitric C, Desilets J, Balayla J, Ziegler C. Surgical Management of the placenta accreta spectrum: An institutional experience. [Internet]. J Obstet Gynaecol Can. 2019;41(11):1551–557. Tersedia dari: https://doi.org/10.1016/j.jogc.2019.01.016
Copyright (c) 2024 Radhillah Azman, Isngadi isngadi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.